Home › Funds › 5AM Venture Management, LLC › CLDX
5AM Venture Management, LLC position in CLDX
CELLDEX THERAPEUTICS INC NEW · Health Care
5AM Venture Management, LLC reported holding 422,270 shares of CLDX (CELLDEX THERAPEUTICS INC NEW) in its Q3 2026 13F filing — a position valued at US$13.7M, representing 4.61% of its reported portfolio and ranking #7 among its reported holdings. 5AM Venture Management, LLC has disclosed CLDX holdings in 13 of the last 13 reported quarters, going back to Q3 2023.
Last updated: 2026-11-17 · Source: SEC EDGAR Form 13F-HR
How 5AM Venture Management, LLC's CLDX position evolved
5AM Venture Management, LLC first disclosed a stake in CLDX in Q3 2023 at 310,270 shares (US$8.5M). The position peaked in Q1 2024 at 497,270 shares, worth US$20.9M. Across 13 filings, 5AM Venture Management, LLC increased the stake 1 time(s), trimmed it 1 time(s) and left it unchanged 10 time(s). The most recent filing (Q3 2026) shows 422,270 shares valued at US$13.7M — a reduction of -75,000 shares quarter over quarter.. Notable position changes include a 60% increase in Q4 2023 (shares rose 6% over the following quarter).
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q3 2023 | 310.27K | $8.54M | New |
| Q4 2023 | 497.27K | $19.72M | Add |
| Q1 2024 | 497.27K | $20.87M | Hold |
| Q2 2024 | 497.27K | $18.40M | Hold |
| Q3 2024 | 497.27K | $16.90M | Hold |
| Q4 2024 | 497.27K | $12.57M | Hold |
| Q1 2025 | 497.27K | $9.03M | Hold |
| Q2 2025 | 497.27K | $10.12M | Hold |
| Q3 2025 | 497.27K | $12.86M | Hold |
| Q4 2025 | 497.27K | $13.51M | Hold |
| Q1 2026 | 497.27K | $15.77M | Hold |
| Q2 2026 | 497.27K | $18.50M | Hold |
| Q3 2026 | 422.27K | $13.69M | Reduce |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About CLDX and 13F data
CLDX (CELLDEX THERAPEUTICS INC NEW) is a Health Care company. 36 other funds we track also report a position in CLDX — the largest reported positions include Kynam Capital Management, LP (US$164.2M), BAKER BROS. ADVISORS LP (US$83.1M), Deep Track Capital, LP (US$68.9M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding CLDX
- Kynam Capital Management, LP 5.07M sh · $164.19M · Q3 2026
- BAKER BROS. ADVISORS LP 2.56M sh · $83.13M · Q3 2026
- Deep Track Capital, LP 2.13M sh · $68.89M · Q3 2026
- EVENTIDE ASSET MANAGEMENT, LLC 1.90M sh · $61.46M · Q3 2026
- Eversept Partners, LP 1.17M sh · $38.07M · Q3 2026
- Affinity Asset Advisors, LLC 1.16M sh · $37.61M · Q3 2026
- Elmind Capital, LP 1.11M sh · $35.98M · Q3 2026
- Commodore Capital LP 1.00M sh · $32.41M · Q3 2026
- Novo Holdings A/S 950.00K sh · $30.79M · Q3 2026
- Frazier Life Sciences Management, L.P. 900.08K sh · $29.17M · Q3 2026
- ADAR1 Capital Management, LLC 799.30K sh · $25.91M · Q3 2026
- Trails Edge Capital Partners, LP 765.00K sh · $24.79M · Q3 2026
More on 5AM Venture Management, LLC
FAQ
How long has 5AM Venture Management, LLC held CLDX?
5AM Venture Management, LLC has disclosed CLDX holdings in 13 of the last 13 reported quarters, going back to Q3 2023.
What is 5AM Venture Management, LLC's current position in CLDX?
As of Q3 2026, 5AM Venture Management, LLC holds 422.27K shares of CLDX (CELLDEX THERAPEUTICS INC NEW), valued at $13.69M, representing 4.61% of its reported portfolio and ranking #7.
Has 5AM Venture Management, LLC been buying or selling CLDX?
In the latest 13F filing (Q3 2026), 5AM Venture Management, LLC reduced its position in CLDX. The position peaked in Q1 2024 at 497.27K shares.
Which other funds hold CLDX?
Other major institutional holders of CLDX include Kynam Capital Management, LP, BAKER BROS. ADVISORS LP, Deep Track Capital, LP, among 36 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.